Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ranibizumab (lucentis) (4 trials)
ico-007 (1 trial)
prednisone (meticorten) (1 trial)
urea (1 trial)
aflibercept (zaltrap) (1 trial)
bevacizumab (avastin) (1 trial)
pegpleranib (Fovista) (1 trial)
sirolimus (rapamune) (1 trial)
triamcinolone (kenalog) (1 trial)
Diabetes Mellitus (Phase 2)
Diabetic Retinopathy (Phase 1)
Edema (Phase 2)
Macular Degeneration (Phase 4)
Macular Edema (Phase 2)
Retinal Diseases (Phase 1)
Wet Macular Degeneration (Phase 4)
Trials (7 total)
Trial APIs (9 total)